Lymphoma

#90395 NCT01086644
Title: To determine the optimal and maximum tolerated dose of CAT-8015 to treat relapsed or refractory selected types of lymphoma
Study Location: Temple Main Campus

#90569 NCT00608361
Title: Dasatinib in Treating Patients with Metastatic or Unresectable Solid Tumor or Lymphoma
Study Location: Temple Main Campus

Leukemia

#50148 NCT00074282
Title: Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath-1H for Previously Treated Relapsed or REfractory Patients with Chronic Lymphocytic Leukemia
Study Location: Temple Main Campus

#90395 NCT01086644
Title: A Phase ½ Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia
Study Location: Temple Main Campus

Myeloma

#120127 NCT01568866
Title: A Randomized, Open-label, Phase III Study of Carfilzomib Plus Dexamethasone vs. Bortezomib Plus Dexamethasone in Patients with Relapsed Multiple Myeloma (ENDEAVOR)
Study Location: Temple Main Campus

For more information or to enroll in a study please call: 1-254-724-5407

---

Print

Share

eMail

Text Size

A

A

A